Imperial College London


Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Reader in Computational Bioinformatics



+44 (0)20 7594 3160t.ebbels Website




131Sir Alexander Fleming BuildingSouth Kensington Campus






BibTex format

author = {Steinbeck, C and van, Rijswijk M and Beirnaert, C and Caron, C and Cascante, M and Dominguez, V and Dunn, WB and Ebbels, TMD and Giacomoni, F and Gonzalez-Beltran, A and Hankemeier, T and Haug, K and Izquierdo-Garcia, JL and Jimenez, RC and Jourdan, F and Kale, N and Klapa, MI and Kohlbacher, O and Koort, K and Kultima, K and Le, Corguillé G and Moschonas, NK and Neumann, S and O'Donovan, C and Reczko, M and Rocca-Serra, P and Rosato, A and Salek, RM and Sansone, SA and Satagopam, V and Schober, D and Shimmo, R and Spicer, RA and Spjuth, O and Thévenot, EA and Viant, MR and Weber, RJM and Willighagen, EL and Zanetti, G},
doi = {10.12688/f1000research.12342.1},
journal = {F1000Research},
title = {The future of metabolomics in ELIXIR},
url = {},
volume = {6},
year = {2017}

RIS format (EndNote, RefMan)

AB - Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the "Future of metabolomics in ELIXIR" was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop established metabolite identification as the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community - both industry and academia - would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.
AU - Steinbeck,C
AU - van,Rijswijk M
AU - Beirnaert,C
AU - Caron,C
AU - Cascante,M
AU - Dominguez,V
AU - Dunn,WB
AU - Ebbels,TMD
AU - Giacomoni,F
AU - Gonzalez-Beltran,A
AU - Hankemeier,T
AU - Haug,K
AU - Izquierdo-Garcia,JL
AU - Jimenez,RC
AU - Jourdan,F
AU - Kale,N
AU - Klapa,MI
AU - Kohlbacher,O
AU - Koort,K
AU - Kultima,K
AU - Le,Corguillé G
AU - Moschonas,NK
AU - Neumann,S
AU - O'Donovan,C
AU - Reczko,M
AU - Rocca-Serra,P
AU - Rosato,A
AU - Salek,RM
AU - Sansone,SA
AU - Satagopam,V
AU - Schober,D
AU - Shimmo,R
AU - Spicer,RA
AU - Spjuth,O
AU - Thévenot,EA
AU - Viant,MR
AU - Weber,RJM
AU - Willighagen,EL
AU - Zanetti,G
DO - 10.12688/f1000research.12342.1
PY - 2017///
SN - 2046-1402
TI - The future of metabolomics in ELIXIR
T2 - F1000Research
UR -
UR -
VL - 6
ER -